Evidence map›Paper›PMID 42441274›Full record

ArticleiScience2026

Synergistic

Aurélien Stab, Guillaume Ollitrault, Florence Severac, Olivier Taboureau, Lucie Oziol, Maya Bimbot, Grégoire Hervé

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aurélien StabR&D Laboratory and Technical Department, NYCO, 75008 Paris, France.
Guillaume OllitraultInserm U1133, CNRS UMR 8251, Université Paris Cité, Paris, France.
Florence SeveracR&D Laboratory and Technical Department, NYCO, 75008 Paris, France.
Olivier TaboureauInserm U1133, CNRS UMR 8251, Université Paris Cité, Paris, France.
Lucie OziolUniversity Paris-Saclay, CNRS, AgroParisTech, Ecologie Systématique Evolution, Gif-sur-Yvette 91190, France.
Maya BimbotUniversity Paris-Saclay, CNRS, AgroParisTech, Ecologie Systématique Evolution, Gif-sur-Yvette 91190, France.
Grégoire HervéR&D Laboratory and Technical Department, NYCO, 75008 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organophosphates (OPs) are ubiquitous environmental contaminants used in applications ranging from agriculture to home electronics. Their endocrine-disrupting properties have primarily been investigated for a limited number of legacy compounds. Here, we developed an

Indexed as

Environmental scienceEnvironmental toxicologyToxicology

Identifiers

PMID42441274
PMCPMC13335010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.